leish-f2
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2009 (NCT01011309)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Leishmania sp.Immunity, active
Leishmania sp. immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- leish-f2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01011309 | Phase 2 | Oct 1, 2009 | Immune Design, Infectious Disease Research Institute |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Immune Design | For profit | 1 | 0 | 1 | 2009 |
| Infectious Disease Research Institute | Academic/Hospital | 1 | 1 | 1 | 2009 |
2 organizations
Page 1 / 1